Bristol Myers partners with Microsoft for AI-driven lung cancer detection

Bristol Myers Squibb said on Tuesday it ‍had signed an agreement with Microsoft to use the tech ⁠company’s AI-enabled radiology platform to help speed up early detection of lung cancer.

The collaboration will deploy US Food and Drug ‌Administration-cleared radiology ‌AI algorithms through Microsoft’s Precision Imaging Network, which analyzes X-ray and CT ‌images to help identify lung disease and is used by hospitals in the United States, the companies said.

Bristol Myers said the tools could help clinicians spot hard-to-detect ​lung nodules and identify some patients ​at earlier stages of disease.